To J&J it doesn't matter, but it's a useful number to understand the industry as a whole.

When a pharmaceutical leader says that developing new drugs "isn't profitable," it would be nice to know if that meant "clinical trials don't make as much money as cosmetic drugs" or "clinical trials actively lose us money."